S. 3048119th CongressIn committeeLatest action Oct 23, 2025Decoded by AI · checked against the record
The plain-language version leads. The official text is always the reference.
The TREATS Act would let doctors prescribe addiction treatment medications after a telehealth visit instead of requiring an in-person exam.
40-second read · 4 questions answered below
The bill would amend the Controlled Substances Act to allow a telehealth evaluation, done by real-time phone or video call, to substitute for the currently required in-person medical evaluation before prescribing schedule III, IV, or V medications approved to treat substance use disorders, such as buprenorphine. It would make permanent a flexibility that was temporarily allowed during the COVID-19 pandemic.
The bill affects people seeking treatment for substance use disorders, particularly in rural or underserved areas, and doctors and healthcare providers who prescribe these medications. It could also affect telehealth companies and addiction treatment programs.
The change would alter longstanding federal requirements for in-person evaluation before prescribing certain controlled substances, shifting more addiction treatment decisions to remote consultations.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.